XML 29 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Apr. 30, 2021
Apr. 30, 2020
Income Statement [Abstract]    
Net sales $ 147,469 $ 147,540
Cost of products sold 123,476 124,113
Gross profit 23,993 23,427
Operating expenses 25,309 25,772
Operating loss (1,316) (2,345)
Pension expense (1,153) (454)
Other income, net 241 426
Interest expense (389) (493)
Loss before income taxes (2,617) (2,866)
Income tax expense (benefit) 990 1,758
Net loss (3,607) (4,624)
Less: net earnings attributable to the non-controlling interest 65 63
Net loss attributable to Kewaunee Scientific Corporation $ (3,672) $ (4,687)
Net loss per share attributable to Kewaunee Scientific Corporation stockholders    
Basic (in usd per share) $ (1.33) $ (1.70)
Diluted (in usd per share) $ (1.33) $ (1.70)
Weighted average number of common shares outstanding    
Basic (in shares) 2,760 2,750
Diluted (in shares) 2,760 2,750